High frequency of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice created from two different strains of mice
Authors:
- Björn CarlssonBCBjörn Carlsson
- Per PohjanenPPPer Pohjanen
- Håkan WennboHWHåkan Wennbo
- Lars RymoLRLars Rymo
- Olle IsakssonOIOlle Isaksson
- 1 September 1992
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 43 (1-3) , 237-242
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Induction of mammary adenocarcinomas in metallothionein promoter‐human growth hormone transgenic miceInternational Journal of Cancer, 1991
- MOLECULAR EVIDENCE FOR THE PRESENCE OF GROWTH HORMONE RECEPTORS IN THE BOVINE MAMMARY GLANDJournal of Endocrinology, 1990
- New Murine Model for Hepatocellular Carcinoma: Transgenic Mice Expressing Metallothionein--Ovine Growth Hormone Fusion GeneJNCI: Journal of the National Cancer Institute, 1990
- Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogeneCell, 1989
- Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female miceCell, 1988
- The int genes in mammary tumorigenesis and in normal developmentTrends in Genetics, 1988
- Dwarf mice produced by genetic ablation of growth hormone-expressing cells.Genes & Development, 1988
- ACROMEGALYClinical Endocrinology, 1987
- Elevated Growth Hormone Levels in Sera from Breast Cancer PatientsHormone and Metabolic Research, 1985
- Metallothionein-Human GH Fusion Genes Stimulate Growth of MiceScience, 1983